SelectQuote Reports Q1 2027 Results with Strategic Shift Toward Profitability
SelectQuote (SLQT) reported first-quarter fiscal 2027 results characterized by a deliberate reduction in revenue as the company prioritizes profitability and cash flow over sheer policy volume. Consolidated revenue fell 15% year-over-year to $280 million, driven by a smaller senior agent force and pricing headwinds from the Inflation Reduction Act. Despite the top-line decline, the company saw significant improvements in adjusted EBITDA margins across several segments. The Healthcare Services segment faced revenue pressure due to lower drug prices but achieved a 56% growth in adjusted EBITDA through manufacturer reimbursements. Meanwhile, the Life segment's adjusted EBITDA rose 31%. Management remains focused on long-term efficiency, citing $30 million in permanent cost savings and the implementation of Voice AI tools to optimize agent productivity as they head into the Annual Enrollment Period.
Tickers: $SLQT
Topics: EBITDA improvement Inflation Reduction Act impact Medicare Advantage revenue decline
Read the full article at Motley Fool
Part of the story NewtekOne Reports Q3 2026 Results Amid Strategic Shift Toward Recurring Interest Income (15 articles)